Tiny molecules may hold key to septic shock immune failure

This study looks at small molecules called miRNAs in the blood of patients with septic shock. The goal is to understand why some patients develop a weakened immune system after sepsis, which can lead to more infections and higher risk of death. Researchers will compare miRNA patterns between septic shock patients and other critically ill patients to find early markers of immune suppression. The study does not test a new treatment but aims to gather knowledge that could guide future therapies.